Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Telomerase Mediates Vascular Endothelial Growth Factor-dependent Responsiveness in a Rat Model of Hind Limb Ischemia*
Germana Zaccagnini,
Carlo Gaetano¶,
Linda Della Pietra||,
Simona Nanni||**,
Annalisa Grasselli||,
Antonella Mangoni,
Roberta Benvenuto¶,
Manuela Fabrizi¶,
Silvia Truffa¶,
Antonia Germani,
Fabiola Moretti||,
Alfredo Pontecorvi||,
Ada Sacchi||,
Silvia Bacchetti||,
Maurizio C. Capogrossi¶, , and
Antonella Farsetti||¶¶
Laboratory of Vascular Biology and Gene Therapy, Cardiology Center "I. Monzino," Milan 20138, Italy, ¶Laboratory of Vascular Pathology, Istituto Dermopatico dell'Immacolata, Rome 00167, Italy, ||Department of Experimental Oncology, Molecular Oncogenesis Laboratory, Regina Elena Institute-Centro Ricerca Sperimentali, Rome 00158, Italy, Institute of Medical Pathology, Catholic University, Rome 00168, Italy, and Institute of Neurobiology and Molecular Medicine, National Research Council, Rome 00137, Italy
Abstract:
Telomere dysfunction contributes to reduced cell viability,altered differentiation, and impaired regenerative/proliferativeresponses. Recent advances indicate that telomerase activityconfers a pro-angiogenic phenotype to endothelial cells andtheir precursors. We have investigated whether telomerase contributesto tissue regeneration following hind limb ischemia and vascularendothelial growth factor 165 (VEGF165) treatment. VEGF deliveryinduced angiogenesis and increased expression of the telomerasereverse transcriptase (TERT) and telomerase activity in skeletalmuscles and satellite and endothelial cells. Adenovirus-mediatedtransfer of wild type TERT but not of a dominant negative mutant,TERTdn, significantly induced capillary but not arteriole formation.However, when co-delivered with VEGF, TERTdn abrogated VEGF-dependentangiogenesis, arteriogenesis, and blood flow increase. Thiseffect was paralleled by in vitro evidence that telomerase inhibitionby 3'-azido-3'-deoxythymidine in VEGF-treated endothelial cellsstrongly reduced capillary density and promoted apoptosis inthe absence of serum. Similar results were obtained with adenovirus-mediatedexpression of TERTdn and AKTdn, both reducing endogenous TERTactivity and angiogenesis on Matrigel. Mechanistically, neo-angiogenesisin our system involved: (i) VEGF-dependent activation of telomerasethrough the nitric oxide pathway and (ii) telomerase-dependentactivation of endothelial cell differentiation and protectionfrom apoptosis. Furthermore, detection of TERT in activatedsatellite cells identified them as VEGF targets during muscleregeneration. Because TERT behaves as an angiogenic factor anda downstream effector of VEGF signaling, telomerase activityappears required for VEGF-dependent remodeling of ischemic tissueat the capillaries and arterioles level.
Received for publication December 29, 2004.
* This work was supported in part by grants of Ministero dellaSalute (to M. C. C., A. F., and C. G.), Associazione Italianaper la Ricerca sul Cancro (to A. F., and C. G.), and ProgettoStrategico MIUR-CNR (Legge 449/97). The costs of publicationof this article were defrayed in part by the payment of pagecharges. This article must therefore be hereby marked "advertisement"in accordance with 18 U.S.C. Section 1734 solely to indicatethis fact.
Both authors contributed equally to this work.
** Supported by Federazione Italiana Ricerca sul Cancro fellowship.
¶¶ To whom correspondence should be addressed: Dept. of Experimental Oncology, Molecular Oncogenesis, Regina Elena Institute-CRS, Via delle Messi d'Oro 156, 00158 Roma, Italy. Tel.: 39-0652662531; Fax: 39-064180526; E-mail: farsetti{at}ifo.it.
The editors suggest the following Related Resources on Science sites:
B. Illi, C. Colussi, J. Rosati, F. Spallotta, S. Nanni, A. Farsetti, M. C. Capogrossi, and C. Gaetano (2011)
Cardiovasc Res
90, 447-456
|Abstract »|Full Text »|PDF »
Biologic function and clinical potential of telomerase and associated proteins in cardiovascular tissue repair and regeneration.
R. Madonna, R. De Caterina, J. T. Willerson, and Y.-J. Geng (2011)
Eur. Heart J.
32, 1190-1196
|Abstract »|Full Text »|PDF »
Smad-Interacting Protein-1 and MicroRNA 200 Family Define a Nitric Oxide-Dependent Molecular Circuitry Involved in Embryonic Stem Cell Mesendoderm Differentiation.
J. Rosati, F. Spallotta, S. Nanni, A. Grasselli, A. Antonini, S. Vincenti, C. Presutti, C. Colussi, C. D'Angelo, A. Biroccio, et al. (2011)
Arterioscler Thromb Vasc Biol
31, 898-907
|Abstract »|Full Text »|PDF »
Human cardiac and bone marrow stromal cells exhibit distinctive properties related to their origin.
A. Rossini, C. Frati, C. Lagrasta, G. Graiani, A. Scopece, S. Cavalli, E. Musso, M. Baccarin, M. Di Segni, F. Fagnoni, et al. (2011)
Cardiovasc Res
89, 650-660
|Abstract »|Full Text »|PDF »
Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia.
S. Greco, M. De Simone, C. Colussi, G. Zaccagnini, P. Fasanaro, M. Pescatori, R. Cardani, R. Perbellini, E. Isaia, P. Sale, et al. (2009)
FASEB J
23, 3335-3346
|Abstract »|Full Text »|PDF »
Nitric oxide deficiency determines global chromatin changes in Duchenne muscular dystrophy.
C. Colussi, A. Gurtner, J. Rosati, B. Illi, G. Ragone, G. Piaggio, M. Moggio, C. Lamperti, G. D'Angelo, E. Clementi, et al. (2009)
FASEB J
23, 2131-2141
|Abstract »|Full Text »|PDF »
Telomere biology in cardiovascular disease: the TERC-/- mouse as a model for heart failure and ageing.
L. S.M. Wong, H. Oeseburg, R. A. de Boer, W. H. van Gilst, D. J. van Veldhuisen, and P. van der Harst (2009)
Cardiovasc Res
81, 244-252
|Abstract »|Full Text »|PDF »
The telomerase tale in vascular aging: regulation by estrogens and nitric oxide signaling.
A. Farsetti, A. Grasselli, S. Bacchetti, C. Gaetano, and M. C. Capogrossi (2009)
J Appl Physiol
106, 333-337
|Abstract »|Full Text »|PDF »
Vascular endothelial senescence: from mechanisms to pathophysiology.
HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment.
C. Colussi, C. Mozzetta, A. Gurtner, B. Illi, J. Rosati, S. Straino, G. Ragone, M. Pescatori, G. Zaccagnini, A. Antonini, et al. (2008)
PNAS
105, 19183-19187
|Abstract »|Full Text »|PDF »
Estrogen Receptor-{alpha} and Endothelial Nitric Oxide Synthase Nuclear Complex Regulates Transcription of Human Telomerase.
A. Grasselli, S. Nanni, C. Colussi, A. Aiello, V. Benvenuti, G. Ragone, F. Moretti, A. Sacchi, S. Bacchetti, C. Gaetano, et al. (2008)
Circ. Res.
103, 34-42
|Abstract »|Full Text »|PDF »
p21 and mTERT are novel markers for determining different ischemic time periods in renal ischemia-reperfusion injury.
K. Hochegger, C. Koppelstaetter, A. Tagwerker, J. M. Huber, D. Heininger, G. Mayer, and A. R. Rosenkranz (2007)
Am J Physiol Renal Physiol
292, F762-F768
|Abstract »|Full Text »|PDF »
Telomerase Regulation of Myofibroblast Differentiation.
T. Liu, B. Hu, M. J. Chung, M. Ullenbruch, H. Jin, and S. H. Phan (2006) 34, 625-633
|Abstract »|Full Text »|PDF »